Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of New MolEcular MarkErs for a persoNalized Therapy in Ovarian Cancer-MEMENTO

NCT06917469 is registered in ClinicalTrials.gov with Centro di Riferimento Oncologico - Aviano as lead sponsor.

NCT NCT06917469
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06917469 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of New MolEcular MarkErs for a persoNalized Therapy in Ovarian Cancer-MEMENTO
Lead sponsor
Centro di Riferimento Oncologico - Aviano
Phase
Observational
Overall status
Completed
Start date
June 20, 2018
Completion date
June 20, 2022
Enrollment
140 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer